Human neuroblastoma cells use either insulin-like growth factor-I or insulin-like growth factor-II in an autocrine pathway via the IGF-I receptor: Variability of IGF, IGF binding protein (IGFBP) and IGF receptor gene expression and IGF and IGFBP secretion in human neuroblastoma cells in relation to cellular proliferation

Regulatory Peptides

Volumn 72, Issue 1, 1997, Pages 19-29

  Kiess, Wieland ^a   Koepf, Gabriele ^a   Christiansen, Holger ^a   Blum, Werner F ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

IGF receptors; Insulin like growth factor; Insulin like growth factor binding proteins; MTT assay; Neuroblastoma; Proliferation

Indexed keywords

SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; GROWTH REGULATION; MITOGENESIS; NEUROBLASTOMA CELL; PRIORITY JOURNAL; REGULATORY MECHANISM;

AUTOCRINE COMMUNICATION; BLOTTING, WESTERN; CELL DIVISION; CULTURE MEDIA, CONDITIONED; DNA, COMPLEMENTARY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; NEUROBLASTOMA; RADIOIMMUNOASSAY; RECEPTOR, IGF TYPE 1; RIBONUCLEASES; RNA, MESSENGER; TUMOR CELLS, CULTURED;

CHANDIPURA VIRUS;

EID: 0030730992     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(97)01026-4     Document Type: Article

References (38)

1. Babajko S., Binoux M. Modulation of retinoic acid of IGF and IGFBP expression in human SK-N-SH neuroblastoma cell. Europ. J. Endocrinol. 134:1996;474-480.
2. Bernardini S., Cianfarani S., Spagnoli A., Annicchiarico-Petruzzelli M., Melino G., Massoud R. Expression and down-regulation by retinoic acid of IGFBP-2 and -4 in medium from human neuroblastoma cells. J. Neuroendocrinol. 6:1994;409-413.
3. Blum W.F., Breier B. Radioimmunoassays for IGFs and IGFBPs4. Growth Regulation. 4(Suppl. 1):1994;11-19.
4. Brodeur G.M., Seeger R.C., Barrett A., Berthold F., Castleberry R.P., D́Angio G., Hartmann O., Hayes F.A., Helson L., Kemshead J., Lampert F., Ninane J., Ohkawa H., Philip T., Pinkerton C.R., Pritchard J., Sawada T., Siegel S., Smith E.I., Tsuchida Y., Voute P.A. International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J. Clin. Oncol. 6:1988;1874-1881.
5. Burke T.W., Vuk-Pavlovic S. IGF-I is a serum component stimulating growth of human neuroblastoma. In Vitro Cell. Dev. Biol. 29A:1993;391-394.
6. Christiansen H., Lampert F. Tumour karyotype discriminates between good and bad prognostic outcome in neuroblastoma. Br. J. Cancer. 57:1988;121-126.
7. Christiansen N.M., Christiansen H., Berthold F., Lampert F. Transcriptional activity of N-myc and ngf-r in 50 primary human neuroblastomas as predictor for clinical outcome. Intern. J. Oncol. 3:1993;853-857.
8. Christofori G., Naik P., Hanahan D. A second signal supplied by IGF-II in oncogene-induced tumourigenesis. Nature. 369:1994;414-417.
9. Cianfarani S., Germani D., Rossi P., Spagnoli A., Mercanti D. Do IGFBPs modulate the IGF-I growth promoting and differentiating effects in human neuroblastoma cells? Eur. J. Endocrinol. 135:1996;716-723.
10. Cohen P.S., Seeger R.C., Triche T.J., Israel M.A. Detection of N-myc gene expression in neuroblastoma tumours by in situ hybridization. Am. J. Pathol. 131:1988;391-397.
11. De Souza A.T., Hankins G.R., Washington M.K., Fine R.L., Orton T.C., Jirtle R.L. Frequent loss of heterozygosity on 6q at the mannose-6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumours. Oncogene. 10:1995;1725-1729.
12. De Souza A.T., Hankins G.R., Washington M.K., Orton T.C., Jirtle R.L. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterocygosity. Nature Genetics. 11:1995;447-449.
13. El-Badry O.M., Romanus J.A., Helman L.J., Cooper M.J., Rechler M.M., Israel M.A. Autonomous growth of a human neuroblastoma cell line is mediated by IGF-II. J. Clin. Invest. 84:1989;829-839.
14. El-Badry O.M., Helman L.J., Chatten J., Steinberg S.M., Evans A.E., Israel M.A. IGF-II mediated proliferation of human neuroblastoma. J. Clin. Invest. 87:1991;648-657.
15. Gaetano C., Matsumoto K., Thiele C.J. Retinoic acid resistant neuroblastoma cells and the expression of IGF-II. Adv. Neuroblastoma Res. 3:1991;165-172.
16. Hirvonen H., Sandberg M., Kalimo H., Hikkanen V., Vuorio E., Salmi T.T., Alitalo K. The N-myc proto-oncogene and IGF-II mRNAs are expressed by distinct cells in human fetal kidney and brain. J. Cell. Biol. 108:1989;1093-1104.
17. Hoeflich A., Wolf E., Braulke T., Koepf G., Kessler U., Brem G., Rascher W., Blum W., Kiess W. Does the overexpression of pro-IGF-II in transfected human embryonic kidney fibroblasts increase the secretion of lysosomal enzymes? Eur. J. Biochem. 232:1995;172-178.
18. Hoeflich A., Yang Y., Koepf G., Blum W.F., Huber S., Kolb H.J., Rascher W., Kiess W. Coordinate expression of IGF-II and IGF-II/M6P receptor mRNA and stable expression of IGF-I receptor mRNA during differentiation of human colon carcinoma cells. Eur. J. Endocrinol. 135:1996;49-59.
19. Hoeflich A., Yang Y., Huber S., Rascher W., Koepf G., Blum W.F., Heinz-Erian P., Kolb H.J., Kiess W. Expression of IGFBP-3 and -4 mRNA but not of IGFBP-2 mRNA correlates with the differentiation of Caco-2 colon epithelial cells. Amer. J. Physiol. 271:1996;E922-E931.
20. Kiefer M.C., Schmid C., Waldvogel M., Schläpfer I., Futo E., Masiarz F.R. Recombinant human IGFBP-4, -5, and -6: biological and physicochemical characterization. Growth Regulation. 3:1993;56-59.
21. Kiess W., Haskell J., Lee L. An antibody that blocks IGF binding to the type II IGF receptor is neither an agonist nor an inhibitor of IGF-stimulated responses in L6 myoblasts. J. Biol. Chem. 262:1987;12745-12751.
22. Korn E., Van Hoff J., Buckley P., Daughaday W.H., Carpenter T.O. Secretion of a large molecular weight form of IGF-II by a primary renal tumour. Med. Pediatr. Oncol. 24:1995;392-396.
23. Kull F.C., Jacobs S., Su Y.F., Svoboda M.E., Van Wyk J.J., Cuatracasas P. Monoclonal antibodies to receptor for insulin and somatomedin C. J. Biol. Chem. 258:1983;6561-6566.
24. Lambert S., Vivario J., Boniver J., Gol-Winkler R. Abnormal expression and structural modification of the IGF-II gene in human colorectal tumours. Int. J. Cancer. 46:1990;405-410.
25. Lampert F., Christiansen H., Christiansen N. Numerical and structural aberrations of chromosome 1 in primary neuroblastomas: indicators for prognostic outcome. Clin. Chem. Enzym. Comms. 5:1993;233-236.
26. Lavenius E., Parrow V., Nanberg E., Pahlman S. Basic FGF and IGF-I promote differentiation of human SH-SY5Y neuroblastoma cells in culture. Growth Factors. 10:1994;29-39.
27. Macaulay W.M. IGFs and cancer. Br. J. Cancer. 65:1992;311-320.
28. Martin D.M., Singleton J.R., Meghani M.A., Feldman E.L. IGF receptor function and regulation in autocrine human neuroblastoma cell growth. Regul. Peptides. 48:1993;225-232.
29. Martin D.M., Feldman E.L. Regulation of IGF-II expression and its role in autocrine growth of human neuroblastoma cells. J. Cell. Physiol. 155:1993;290-300.
30. Matthews C.C., Feldman E.L. IGF-I rescues SH-SX5Y human neuroblastoma cells from hyperosmotic induced programmed cell death. J. Cell. Physiol. 166:1996;323-331.
31. Mattson M.E.K., Engberg G., Ruusula A.I., Hall K., Pahlman S. Mitogenic response of human SH-SY5Y neuroblastoma cells to IGF-I and IGF-II is dependent on the stage of differentiation. J. Cell. Biol. 102:1986;1949-1954.
32. Melino G., Stephanou A., Annicchiarico-Petruzzelli M., Knight R.A., Finazzi-Agro A., Lightman S.L. Modulation of IGF-II expression during growth and differentiation of human neuroblastoma cells: retinoic acid may induce IGF-II. Neurosci. Lett. 151:1993;187-191.
33. Nissley S.P., Lopeszinsky W. IGF receptors. Growth Factors. 5:1991;29-43.
34. Pritchard J., Hickman J.A. Why does stage 4s neuroblastoma regress spontaneously? Lancet. 344:1994;869-870.
35. Raile K., Hoeflich A., Yang Y., Kessler U., Pfünder M., Blum W.F., Kolb H., Schwarz H.P., Kiess W. Human osteosarcoma (U-2 OS) cells express both IGF-I receptors and IGF-II/M6P receptors and synthesize IGF-II: autocrine growth stimulation by IGF-II via the IGF-I receptor. J. Cell. Physiol. 159:1994;531-541.
36. Recio-Pinto E., Ishii D.N. Insulin and IGF receptors regulating neurite formation in cultured human neuroblastoma cells. J. Neurosci. Res. 19:1988;312-320.
37. Ross R.A., Spengler B.A., Biedler J.L. Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J. Natl. Cancer Inst. 4:1983;741-747.
38. Schwab M., Alitalo K., Klempnauer K.H., Varmus H.E., Bishop J.M., Gilbert F., Brodeur G., Goldstein M., Trent J. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma celll lines and a neuroblastoma tumour. Nature. 305:1983;245-248.